Literature DB >> 22172508

Antigen-loaded dissolving microneedle array as a novel tool for percutaneous vaccination.

Seishiro Naito1, Yukako Ito, Tomoko Kiyohara, Michiyo Kataoka, Masaki Ochiai, Kanji Takada.   

Abstract

Antigen-loaded dissolving microneedle array (dMNA) patches were investigated as novel systems for vaccine delivery into the skin, where immuno-competent dendritic cells are densely distributed. We fabricated micron-scale needles arrayed on patches, using chondroitin sulfate mixed with a model antigen, ovalbumin. Insertion of dMNA effectively delivered substantial amounts of ovalbumin into the skin within 3 min and induced robust antigen-specific antibody responses in the sera of mice. The antibody dose-response relationship showed that the efficiency of dMNA patch immunization was comparable to that of conventional intradermal injections. Thus, Antigen-loaded dMNA patches are a promising antigen-delivery system for percutaneous vaccination.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22172508     DOI: 10.1016/j.vaccine.2011.11.111

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  12 in total

Review 1.  Glucose-Responsive Microneedle Patches for Diabetes Treatment.

Authors:  Guojun Chen; Jicheng Yu; Zhen Gu
Journal:  J Diabetes Sci Technol       Date:  2018-05-31

2.  Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.

Authors:  Maelíosa T C McCrudden; Barbara M Torrisi; Sharifah Al-Zahrani; Cian M McCrudden; Marija Zaric; Christopher J Scott; Adrien Kissenpfennig; Helen O McCarthy; Ryan F Donnelly
Journal:  J Pharm Pharmacol       Date:  2014-03-27       Impact factor: 3.765

3.  A microneedle patch containing measles vaccine is immunogenic in non-human primates.

Authors:  Chris Edens; Marcus L Collins; James L Goodson; Paul A Rota; Mark R Prausnitz
Journal:  Vaccine       Date:  2015-03-12       Impact factor: 3.641

4.  Measles vaccination using a microneedle patch.

Authors:  Chris Edens; Marcus L Collins; Jessica Ayers; Paul A Rota; Mark R Prausnitz
Journal:  Vaccine       Date:  2012-10-05       Impact factor: 3.641

5.  Delivery of subunit influenza vaccine to skin with microneedles improves immunogenicity and long-lived protection.

Authors:  Dimitrios G Koutsonanos; Elena V Vassilieva; Anastasia Stavropoulou; Vladimir G Zarnitsyn; E Stein Esser; Misha T Taherbhai; Mark R Prausnitz; Richard W Compans; Ioanna Skountzou
Journal:  Sci Rep       Date:  2012-04-12       Impact factor: 4.379

Review 6.  Microneedles: A New Frontier in Nanomedicine Delivery.

Authors:  Eneko Larrañeta; Maelíosa T C McCrudden; Aaron J Courtenay; Ryan F Donnelly
Journal:  Pharm Res       Date:  2016-02-23       Impact factor: 4.200

7.  Intradermal Delivery of Antigens Enhances Specific IgG and Diminishes IgE Production: Potential Use for Vaccination and Allergy Immunotherapy.

Authors:  Takuwa Yasuda; Takehiro Ura; Masaru Taniguchi; Hisahiro Yoshida
Journal:  PLoS One       Date:  2016-12-14       Impact factor: 3.240

Review 8.  Microneedles for intradermal and transdermal drug delivery.

Authors:  Tuan-Mazlelaa Tuan-Mahmood; Maelíosa T C McCrudden; Barbara M Torrisi; Emma McAlister; Martin J Garland; Thakur Raghu Raj Singh; Ryan F Donnelly
Journal:  Eur J Pharm Sci       Date:  2013-05-13       Impact factor: 4.384

9.  Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs.

Authors:  Maelíosa T C McCrudden; Ahlam Zaid Alkilani; Cian M McCrudden; Emma McAlister; Helen O McCarthy; A David Woolfson; Ryan F Donnelly
Journal:  J Control Release       Date:  2014-02-17       Impact factor: 9.776

10.  Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles.

Authors:  Jingtong Pan; Wenyi Ruan; Mengyao Qin; Yueming Long; Tao Wan; Kaiyue Yu; Yuanhao Zhai; Chuanbin Wu; Yuehong Xu
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.